255 related articles for article (PubMed ID: 17645976)
41. Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: A report from the silent cerebral infarct transfusion trial.
Darbari DS; Eigbire-Molen O; Ponisio MR; Milchenko MV; Rodeghier MJ; Casella JF; McKinstry RC; DeBaun MR
Am J Hematol; 2018 Dec; 93(12):E406-E408. PubMed ID: 30264867
[No Abstract] [Full Text] [Related]
42. Neurological complications of sickle cell anemia.
Sarnaik SA; Lusher JM
Am J Pediatr Hematol Oncol; 1982; 4(4):386-94. PubMed ID: 7168488
[TBL] [Abstract][Full Text] [Related]
43. [Silent cerebral infarct in patients with sickle cell anemia].
Ferrer O O; Plumacher-Rincón Z; Arteaga-Vizcaíno M; Weir-Medina J; Hernández-Pernía A
Rev Neurol; 2002 Oct 16-31; 35(8):716-9. PubMed ID: 12402221
[TBL] [Abstract][Full Text] [Related]
44. Cognitive screening examinations for silent cerebral infarcts in sickle cell disease.
DeBaun MR; Schatz J; Siegel MJ; Koby M; Craft S; Resar L; Chu JY; Launius G; Dadash-Zadeh M; Lee RB; Noetzel M
Neurology; 1998 Jun; 50(6):1678-82. PubMed ID: 9633710
[TBL] [Abstract][Full Text] [Related]
45. MRI abnormalities in infants with sickle cell anemia-indication for preemptive therapy?
Ozsahin H
Pediatr Blood Cancer; 2008 Nov; 51(5):573-4. PubMed ID: 18623220
[No Abstract] [Full Text] [Related]
46. Neuro-ophthalmological sequelae of sickle cell disease. A case report and review of the literature.
Adeuja AO; Osuntokun O; Essien EM
West Afr J Med; 1990; 9(4):317-20. PubMed ID: 2083212
[TBL] [Abstract][Full Text] [Related]
47. [Synchronous bilateral gangliobasal hemorrhage in a student with sickle cell anemia: a case report].
Moscote Salazar LR; Castellar Leones SM; Alcalá-Cérra G; López W
Bol Asoc Med P R; 2012; 104(1):58-63. PubMed ID: 22788082
[TBL] [Abstract][Full Text] [Related]
48. Silent cerebral infarct in sickle cell anemia patients of southern Turkey.
Nafile Sayman E; Leblebİsatan G; Leblebisatan Ş; Bıçakcı YK; Kılınç Y; Barutçu A
Turk J Med Sci; 2020 Dec; 50(8):1887-1893. PubMed ID: 32599969
[TBL] [Abstract][Full Text] [Related]
49. Molecular and environmental contributors to neurological complications in sickle cell disease.
Karkoska KA; Gollamudi J; Hyacinth HI
Exp Biol Med (Maywood); 2023 Aug; 248(15):1319-1332. PubMed ID: 37688519
[TBL] [Abstract][Full Text] [Related]
50. Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.
Carpenter JL; Nickel RS; Webb J; Khademian Z; Speller-Brown B; Majumdar S; Darbari DS; Campbell A; Zhang A; Abraham A
Transplant Cell Ther; 2021 Dec; 27(12):1018.e1-1018.e9. PubMed ID: 34530179
[TBL] [Abstract][Full Text] [Related]
51. Sickle cell disease with regional silent cerebral infarction detected by SPECT.
Yalçin H; Melek I; Okuyucu E; Reyhan M; Akgül F; Serarslan G; Duman T; Yalçin F
Clin Nucl Med; 2007 Nov; 32(11):842-3. PubMed ID: 18075416
[TBL] [Abstract][Full Text] [Related]
52. Hydroxyurea: an alternative to transfusion therapy for stroke in sickle cell anemia.
Ware RE; Steinberg MH; Kinney TR
Am J Hematol; 1995 Oct; 50(2):140-3. PubMed ID: 7572993
[No Abstract] [Full Text] [Related]
53. Use of hydroxyurea from childhood to adult age in sickle cell disease: semen analysis.
Lukusa AK; Vermylen C
Haematologica; 2008 Nov; 93(11):e67; discussion e68. PubMed ID: 18978293
[No Abstract] [Full Text] [Related]
54. Incomplete cerebral infarctions are not silent.
Powars DR; Wong WY; Vachon LA
J Pediatr Hematol Oncol; 2001 Feb; 23(2):79-83. PubMed ID: 11216710
[No Abstract] [Full Text] [Related]
55. Hydroxyurea therapy lowers circulating DNA levels in sickle cell anemia.
Ulug P; Vasavda N; Kumar R; Keir L; Awogbade M; Cunningham J; Rees DC; Menzel S; Thein SL
Am J Hematol; 2008 Sep; 83(9):714-6. PubMed ID: 18615556
[TBL] [Abstract][Full Text] [Related]
56. Intracranial hemorrhage in children with sickle cell disease.
Van Hoff J; Ritchey AK; Shaywitz BA
Am J Dis Child; 1985 Nov; 139(11):1120-3. PubMed ID: 4061407
[TBL] [Abstract][Full Text] [Related]
57. Sickle cell disease complicated by post-streptococcal glomerulonephritis, cerebral hemorrhage and reversible posterior leucoencephalopathy syndrome.
Pashankar FD; Ment LR; Pearson HA
Pediatr Blood Cancer; 2008 Apr; 50(4):864-6. PubMed ID: 17973321
[TBL] [Abstract][Full Text] [Related]
58. Current issues in blood transfusion for sickle cell disease.
Wahl S; Quirolo KC
Curr Opin Pediatr; 2009 Feb; 21(1):15-21. PubMed ID: 19242238
[TBL] [Abstract][Full Text] [Related]
59. Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
Michel M; Habibi A; Godeau B; Bachir D; Lahary A; Galacteros F; Fifi-Mah A; Arfi S
Semin Arthritis Rheum; 2008 Dec; 38(3):228-40. PubMed ID: 18177923
[TBL] [Abstract][Full Text] [Related]
60. Reduced protein C levels--a contributory factor for stroke in sickle cell disease.
Khanduri U; Gravell D; Christie BS; Al Lamki Z; Zachariah M; Cherian E
Thromb Haemost; 1998 Apr; 79(4):879-80. PubMed ID: 9569210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
